作者：
Meletios A,Dimopoulos [1]
;
Albert,Oriol [1]
;
Hareth,Nahi [1]
;
Jesus,San-Miguel [1]
;
Nizar J,Bahlis [1]
;
Saad Z,Usmani [1]
;
Neil,Rabin [1]
;
Robert Z,Orlowski [1]
;
Mieczyslaw,Komarnicki [1]
;
Kenshi,Suzuki [1]
;
Torben,Plesner [1]
;
Sung-Soo,Yoon [1]
;
Dina,Ben Yehuda [1]
;
Paul G,Richardson [1]
;
Hartmut,Goldschmidt [1]
;
Donna,Reece [1]
;
Steen,Lisby [1]
;
Nushmia Z,Khokhar [1]
;
Lisa,O'Rourke [1]
;
Christopher,Chiu [1]
;
Xiang,Qin [1]
;
Mary,Guckert [1]
;
Tahamtan,Ahmadi [1]
;
Philippe,Moreau [1]
;
POLLUX Investigators
作者单位：
From the National and Kapodistrian University of Athens, Athens (M.A.D.); Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona (A.O.), and Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona (J.S.-M.) - both in Spain; Karolinska Institute and the Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm (H.N.); Tom Baker Cancer Centre, University of Calgary, Calgary, AB (N.J.B.), and the Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto (D.R.) - both in Canada; Levine Cancer Institute-Carolinas HealthCare System, Charlotte, NC (S.Z.U.); the Department of Haematology, University College London Hospitals NHS Trust, London (N.R.); the Department of Lymphoma-Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (R.Z.O.); the Department of Hematology and Stem Cell Transplantation, Poznan University of Medical Sciences, Poznan, Poland (M.K.); the Department of Hematology, Japanese Red Cross Medical Center, Tokyo (K.S.); Vejle Hospital and University of Southern Denmark, Vejle (T.P.), and Genmab, Copenhagen (S.L.) - both in Denmark; the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea (S.-S.Y.); the Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem (D.B.Y.); Dana-Farber Cancer Institute, Harvard Medical School, Boston (P.G.R.); University Hospital Heidelberg and the German Cancer Research Center, Heidelberg, Germany (H.G.); Janssen Research and Development, Spring House, PA (N.Z.K., L.O., C.C., X.Q., M.G., T.A.); and the Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France (P.M.).
[1]
DOI
10.1056/NEJMoa1607751
PMID
27705267
发布时间
2022-04-08
换一批
换一批
